New 4D Flow Software Platform Showcased
By Andrew Deutsch Posted on 07 Dec 2016 |
Image: An image generated by the 4D Arterys cardiac flow quantification software (Photo courtesy of Arterys).
A company developing cloud-based medical imaging software has received 510(k) clearance from US FDA for its 4D cardiac flow quantification software.
The software was showcased at the annual Radiological Society of North America (RSNA 2016) meeting. The company also presented new information about clinical applications that use the 4-D flow software.
The Arterys 4D Flow software was developed by Arterys (San Francisco, CA, USA), a company that develops quantitative imaging tools for supporting treatment decisions. The Arterys 4D Flow platform uses cloud computing and advanced analytics techniques.
The 4D cardiac flow quantification technique uses phase-contrast Cardiac Magnetic Resonance (CMR) 3D data that is velocity-encoded in three spatial directions. The data is resolved relative to the 3 spatial dimensions, and time, for the duration of the cardiac cycle, and enables clinicians to visualize, and measure blood patterns in the 3D volume. The 4D Flow sequence is faster and simpler than conventional MRI scans.
CEO of Arterys, Fabien Beckers, said, "This year, RSNA is focusing a lot of attention on breakthrough technological developments that are moving medical imaging into a new era where it's possible to analyze data to help diagnose conditions much quicker, align various stakeholders in the health ecosystem, and mobilize on personalized treatment paths. We believe the Arterys platform will transform clinical practice through powerful, quantitative imaging tools that rapidly generate and analyze unprecedented amounts of data and insights that can support treatment decisions and the delivery of patient care."
Related Links:
Arterys
The software was showcased at the annual Radiological Society of North America (RSNA 2016) meeting. The company also presented new information about clinical applications that use the 4-D flow software.
The Arterys 4D Flow software was developed by Arterys (San Francisco, CA, USA), a company that develops quantitative imaging tools for supporting treatment decisions. The Arterys 4D Flow platform uses cloud computing and advanced analytics techniques.
The 4D cardiac flow quantification technique uses phase-contrast Cardiac Magnetic Resonance (CMR) 3D data that is velocity-encoded in three spatial directions. The data is resolved relative to the 3 spatial dimensions, and time, for the duration of the cardiac cycle, and enables clinicians to visualize, and measure blood patterns in the 3D volume. The 4D Flow sequence is faster and simpler than conventional MRI scans.
CEO of Arterys, Fabien Beckers, said, "This year, RSNA is focusing a lot of attention on breakthrough technological developments that are moving medical imaging into a new era where it's possible to analyze data to help diagnose conditions much quicker, align various stakeholders in the health ecosystem, and mobilize on personalized treatment paths. We believe the Arterys platform will transform clinical practice through powerful, quantitative imaging tools that rapidly generate and analyze unprecedented amounts of data and insights that can support treatment decisions and the delivery of patient care."
Related Links:
Arterys
Latest MRI News
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy